Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Semen quality in patients with pituitary disease and adult-onset hypogonadotropic hypogonadism

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Measurement of urinary 5-HIAA: correlation between spot versus 24-h urine collection

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. GIP-induced vasodilation in human adipose tissue involves capillary recruitment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mitochondrial mutation m.3243A>G associates with insulin resistance in non-diabetic carriers

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Cross-sectional analysis of sleep hours and quality with sex hormones in men

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Gonadotropins (luteinizing hormone (LH) and follicle-stimulating hormone (FSH)) are released from the pituitary gland and stimulate Leydig cells to produce testosterone and initiates spermatogenesis. Little is known about how and when the deterioration of semen quality occurs in patients with adult-onset gonadotropin insufficiency.

DESIGN AND METHODS: A retrospective study comprising 20 testosterone-deficient men (median age, 29 years) with acquired pituitary disease who delivered semen for cryopreservation before initiation of testosterone therapy. Semen variables and hormone concentrations were compared to those of young healthy men (n = 340).

RESULTS: Thirteen of 20 patients (65%) and 82% of controls had total sperm counts above 39 million and progressive motile spermatozoa above 32% (P = 0.05). For the individual semen variables, there were no significant differences in semen volume (median (intraquartile range) 3.0 (1.3-6.8) vs 3.2 (2.3-4.3) mL, P = 0.47), sperm concentration 41 (11-71) vs 43 (22-73) mill/mL (P = 0.56) or total sperm counts (P = 0.66). One patient had azoospermia. Patients vs controls had lower serum testosterone 5.4 (2.2-7.6) vs 19.7 (15.5-24.5) nmol/L (P = 0.001), calculated free testosterone (cfT) 145 (56-183) vs 464 (359-574) pmol/L (P < 0.001), LH 1.5 (1.1-2.1) vs 3.1 (2.3-4.0) U/L (P = 0.002) and inhibin b (P < 0.001). Levels of FSH were similar (P = 0.63). Testosterone/LH ratio and cfT/LH ratio were reduced in patients (both P < 0.001).

CONCLUSIONS: Despite Leydig cell insufficiency in patients with acquired pituitary insufficiency, the majority presented with normal semen quality based on the determination of the number of progressively motile spermatozoa. In addition, the data suggest reduced LH bioactivity in patients with pituitary insufficiency.

Original languageEnglish
JournalEndocrine Connections
Volume7
Issue number4
Pages (from-to)523-533
Number of pages11
ISSN2049-3614
DOIs
Publication statusPublished - Apr 2018

    Research areas

  • Journal Article

ID: 53620714